Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,390.00 at Bank of America

Key Points

• Bank of America has raised its price target for Mettler-Toledo International from $1,260.00 to $1,390.00, indicating a potential upside of 10.57% based on the stock's recent closing price.
• Other analysts have mixed views, with Citigroup setting a higher target of $1,600.00 and Barclays placing a target of $1,325.00, resulting in a consensus rating of "Moderate Buy".
• The company reported earnings of $10.09 EPS for the last quarter, surpassing estimates, and has provided guidance for FY 2025 EPS between 42.100-42.600.

Mettler-Toledo International (NYSE:MTD - Get Free Report) had its price objective lifted by research analysts at Bank of America from $1,260.00 to $1,390.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a "neutral" rating on the medical instruments supplier's stock. Bank of America's target price indicates a potential upside of 10.57% from the stock's previous close.

Several other research analysts also recently issued reports on the stock. Citigroup upped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research report on Thursday, August 21st. Barclays initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target on the stock. Evercore ISI cut their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research report on Monday, August 4th. Finally, Robert W. Baird upped their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $1,325.56.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD traded down $8.44 on Monday, hitting $1,257.15. The stock had a trading volume of 52,830 shares, compared to its average volume of 168,420. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,521.01. The firm's 50 day moving average price is $1,264.75 and its 200-day moving average price is $1,185.20. The company has a market capitalization of $25.90 billion, a price-to-earnings ratio of 31.80, a price-to-earnings-growth ratio of 3.79 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. The company had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts predict that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In other news, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares of the company's stock, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gerry Keller sold 165 shares of the stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the sale, the insider directly owned 94 shares of the company's stock, valued at approximately $123,012.16. The trade was a 63.71% decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,827 shares of company stock valued at $2,371,208 in the last ninety days. 0.77% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several large investors have recently made changes to their positions in the stock. Farther Finance Advisors LLC lifted its holdings in Mettler-Toledo International by 39.1% during the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after purchasing an additional 25 shares during the last quarter. QRG Capital Management Inc. lifted its holdings in Mettler-Toledo International by 29.4% during the 1st quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock valued at $577,000 after purchasing an additional 111 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Mettler-Toledo International by 13.3% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock valued at $2,929,000 after purchasing an additional 292 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Mettler-Toledo International by 95.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock valued at $2,600,000 after purchasing an additional 1,073 shares during the last quarter. Finally, Boston Trust Walden Corp lifted its holdings in Mettler-Toledo International by 7.1% during the 1st quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock valued at $40,871,000 after purchasing an additional 2,296 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.